1. Search Result

Search Result

Results for "90825-43-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-13682B
    Mifamurtide sodium

    MTP-PE sodium; L-MTP-PE sodium; CGP 19835 sodium

    Others Cancer Inflammation/Immunology
    Mifamurtide sodium (MTP-PE sodium), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide sodium, an orphan drug, is a specific ligand of NOD2 used as an insulin sensitizer. Mifamurtide sodium has the potential for osteosarcoma research.
  • HY-13682C
    Mifamurtide TFA

    MTP-PE TFA; L-MTP-PE TFA; CGP 19835 TFA

    Others Cancer Inflammation/Immunology
    Mifamurtide TFA (MTP-PE TFA), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide TFA, an orphan drug, is a specific ligand of NOD2 used as an insulin sensitizer. Mifamurtide TFA has the potential for osteosarcoma research.
  • HY-13682
    Mifamurtide

    MTP-PE; L-MTP-PE; CGP 19835

    Others Cancer Inflammation/Immunology
    Mifamurtide (MTP-PE), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide, an orphan drug, is a specific ligand of NOD2 used as an insulin sensitizer. Mifamurtide has the potential for osteosarcoma research.